Table 1.

The median serum C-reactive protein to albumin ratio (CAR) before and three months after biological agent treatment

	CAR median (interquartile range)
	before treatment		after treatment	P
Adalimumab (n = 65)		0.79 (0.52-1.14)	0.62 (0.36-1.02)	<0.001
Ustekinumab (n = 42)		0.90 (0.63-1.73)	0.82 (0.56-1.34)	0.006
Infliximab (n = 32)		1.08 (0.64-1.85)	0.84 (0.48-1.23)	0.007
Secukinumab (n = 18)		1.52 (1.01-3.04)	0.84 (0.62-0.99)	<0.001
All patients (n = 157)		0.97 (0.61-1.61)	0.73 (0.45-1.11)	<0.001
Patients with arthritis (n = 31)		1.01 (0.66-1.01)	0.80 (0.40-1.38)	0.002
Patients without arthritis (n = 126)		0.95 (0.58-1.59)	0.72 (0.47-1.06)	<0.001